from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1448c/tal

LFCtreatmentdescriptionclass of inhibitor

-2.578

Amikacinug/mL Amikacintranslation

-3.237

Cap5-10ug/mL Capreomycintranslation

-4.534

Rox10-50 ug/mL Roxithromycintranslation

-0.611

SM2-5 ug/mL Streptomycintranslation

-4.214

Tet5-10 ug/mL Tetracyclinetranslation

-0.338

Rif0.2-5ug/mL Rifampicintranscription

-1.583

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.176

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.103

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.127

CPZ10-50 ug/mL Chlorpromazinerespiration

0.074

Clofazimine10-13 ug/mL Clofaziminerespiration

0.215

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.080

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.616

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.412

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.243

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.434

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.152

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.339

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.097

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.310

KCN5-20 ug/mL Potassium cyaniderespiration

0.464

NaN30.2-2 mM Sodium aziderespiration

0.045

Nigericin50 uM Nigericinrespiration

0.531

TRC10-150 ug/mL Triclosanrespiration

0.302

TRZ10-25 ug/mL Thioridazinerespiration

-1.250

Valinomycin0.5-10 uM Valinomycinrespiration

-0.173

ZnSO42 mM ZnSO4respiration

-0.481

menadione6-10 ug/mL Menadionerespiration

0.274

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.138

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.223

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.291

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.529

NRP_1Non-replicating persistence stage 1dosRassociated

-0.025

Amp0.2mg/mL AmpicillincellWall

0.026

Cephalexin20-100 ug/mL CephalexincellWall

-0.155

Cerulenin0.32-5 ug/mL CerulenincellWall

0.614

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.374

EMB10-20 ug/mL EthambutolcellWall

0.185

Eta12-40 ug/mL EthionamidecellWall

0.010

INH0.2-0.4 ug/mL IsoniazidcellWall

0.251

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.364

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.259

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.469

BZA0.12 mg/mL BenzamidearomaticAmides

0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.213

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.153

H2O24 mM hydrogen peroxideDNAdamaging

0.465

Levo10 ug/mL LevofloxacinDNAdamaging

0.616

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.015

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.306

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.761

UVUV-irradiationDNAdamaging

-1.138

ARP41-4 ug/mL Antitubercular compound ARP4?

0.287

Antimycin12.5-50 ug/mL Antimycin A?

-0.337

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.657

PA_110-50 ug/mL Antitubercular compound PA-1?

0.798

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.298

PA8240.2-2 ug/mL PA-824?

0.019

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.313

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.098

Verapamil50 uM Verapamil?

-0.255

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.294

methoxatin10-20 ug/mL Methoxatin?